These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26416497)

  • 1. Phosphate and FGF-23 homeostasis after kidney transplantation.
    Baia LC; Heilberg IP; Navis G; de Borst MH;
    Nat Rev Nephrol; 2015 Nov; 11(11):656-66. PubMed ID: 26416497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferric carboxymaltose-induced hypophosphataemia after kidney transplantation.
    Sari V; Atiqi R; Hoorn EJ; Heijboer AC; van Gelder T; Hesselink DA
    Neth J Med; 2017 Mar; 75(2):65-73. PubMed ID: 28276325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal phosphate loss in long-term kidney transplantation.
    Sirilak S; Chatsrisak K; Ingsathit A; Kantachuvesiri S; Sumethkul V; Stitchantrakul W; Radinahamed P; Disthabanchong S
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):323-31. PubMed ID: 22134626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.
    Larsson T; Nisbeth U; Ljunggren O; Jüppner H; Jonsson KB
    Kidney Int; 2003 Dec; 64(6):2272-9. PubMed ID: 14633152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tertiary 'hyperphosphatoninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients.
    Evenepoel P; Naesens M; Claes K; Kuypers D; Vanrenterghem Y
    Am J Transplant; 2007 May; 7(5):1193-200. PubMed ID: 17359508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?
    Bhan I; Shah A; Holmes J; Isakova T; Gutierrez O; Burnett SM; Jüppner H; Wolf M
    Kidney Int; 2006 Oct; 70(8):1486-94. PubMed ID: 16941023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation.
    Young A; Hodsman AB; Boudville N; Geddes C; Gill J; Goltzman D; Jassal SV; Klarenbach S; Knoll G; Muirhead N; Prasad GV; Treleaven D; Garg AX;
    Am J Kidney Dis; 2012 Jun; 59(6):761-9. PubMed ID: 22093959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Earlier decrease of FGF-23 and less hypophosphatemia in preemptive kidney transplant recipients.
    Barros X; Torregrosa JV; Martínez de Osaba MJ; Casals G; Paschoalin R; Durán CE; Campistol JM
    Transplantation; 2012 Oct; 94(8):830-6. PubMed ID: 23018879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor kidney transplantation: a 1-year prospective observational study.
    Kawarazaki H; Shibagaki Y; Fukumoto S; Kido R; Nakajima I; Fuchinoue S; Fujita T; Fukagawa M; Teraoka S
    Nephrol Dial Transplant; 2011 Aug; 26(8):2691-5. PubMed ID: 21303965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
    Nakai K; Komaba H; Fukagawa M
    J Nephrol; 2010; 23(6):619-25. PubMed ID: 20658451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum klotho: relation to fibroblast growth factor-23 and other regulators of phosphate metabolism in children with chronic kidney disease.
    Sawires HK; Essam RM; Morgan MF; Mahmoud RA
    Nephron; 2015; 129(4):293-9. PubMed ID: 25766835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation.
    Evenepoel P; Meijers BK; de Jonge H; Naesens M; Bammens B; Claes K; Kuypers D; Vanrenterghem Y
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1829-36. PubMed ID: 18922992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphate homeostasis and disorders.
    Manghat P; Sodi R; Swaminathan R
    Ann Clin Biochem; 2014 Nov; 51(Pt 6):631-56. PubMed ID: 24585932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower serum fibroblast growth factor-23 levels may suggest malnutrition in maintenance haemodialysis patients.
    Mizuiri S; Nishizawa Y; Yamashita K; Ono K; Oda M; Usui K; Shigemoto K
    Nephrology (Carlton); 2014 Sep; 19(9):568-73. PubMed ID: 24947687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 23 in chronic kidney disease: New insights and clinical implications.
    Damasiewicz MJ; Toussaint ND; Polkinghorne KR
    Nephrology (Carlton); 2011 Mar; 16(3):261-8. PubMed ID: 21265930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated fibroblast growth factor 23 levels as a cause of early post-renal transplantation hypophosphatemia.
    Han SY; Hwang EA; Park SB; Kim HC; Kim HT
    Transplant Proc; 2012 Apr; 44(3):657-60. PubMed ID: 22483462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism.
    Serra AL; Wuhrmann C; Wüthrich RP
    Am J Kidney Dis; 2008 Dec; 52(6):1151-7. PubMed ID: 18950915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast Growth Factor 23 in Postrenal Transplant: An Often Forgotten Hormone.
    Amiri FS; Khatami MR
    Exp Clin Transplant; 2016 Dec; 14(6):606-616. PubMed ID: 27934558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Phosphorus, Parathyroid Hormone, and Serum Fibroblast Growth Factor-23 in Egyptian Patients Six Months after Undergoing Living-donor Kidney Transplantation.
    Kamel MH; Ahmed DH; Mikhael ES; Abdalla MS; Sadek KM; ElNahid MS
    Saudi J Kidney Dis Transpl; 2022; 33(3):353-360. PubMed ID: 37843136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.